foxo4-dri senolytic animal model 2023 2024 The disordered p53 transactivation domain is the target of FOXO4 and the compound Targeting the FOXO4-p53 axis by
Targeting the FOXO4 p53 axis by retro inverso peptide senolytic agents: a pharmacological strategy to mitigate brain aging and cognitive decline Naunyn Schmiedeberg's Archives of Pharmacology Springer Nature Link FOXO4 DRI part 1 , #peptide #molecule #research #health #information PDF) The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Peptide inhibitors targeting FOXO4 p53 interactions and inducing senescent cancer cell specific apoptosis bioRxiv FOXO4 DRI induces keloid senescent fibroblast apoptosis by promoting nuclear exclusion of upregulated p53 serine 15 phosphorylation Communications Biology Cellular Senescence in Health, Disease, and Lens Aging
Pay in 4 interest-free payments of $6.92 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15




